WVE
NASDAQ · Pharmaceuticals
Wave Life Sciences Ltd
$7.18
-0.06 (-0.83%)
Performance
1D
—
1W
—
1M
—
3M
-47.48%
6M
-1.10%
1Y
+8.79%
YTD
-54.98%
Open$7.19
Previous Close$7.24
Day High$7.29
Day Low$7.10
52W High$21.73
52W Low$5.02
Volume—
Avg Volume4.42M
Market Cap1.40B
P/E Ratio—
EPS$-1.21
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$14.99
Below
SMA 200
$9.39
Below
RSI (14)
51.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+765.5% upside
Current
$7.18
$7.18
Target
$62.14
$62.14
$36.97
$62.14 avg
$84.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 48.39M | 106.37M | 444.96M |
| Net Income | -231,502,520 | -85,743,561 | 100.99M |
| Profit Margin | -478.3% | -85.1% | 22.7% |
| EBITDA | -239,488,000 | -96,364,571 | 186.52M |
| Free Cash Flow | — | — | 121.04M |
| Rev Growth | +127.1% | +38.3% | +21.0% |
| Debt/Equity | — | — | 0.53 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |